Paving the Way for Breakthroughs in Oral Cancer Research
In the relentless pursuit of advancing our understanding and treatment of Oral cancer, Oracle Cancer Trust played a pivotal role in funding a groundbreaking research project led by Leah Ambler, a PhD student, that has contributed to two major publications that promise to reshape our approach to identifying metastatic cells in human oral cancer tissue.
The first of these groundbreaking research outputs is a paper published in eLife titled “Identification of Metastatic Cells in Human Oral Cancer Tissue.” The study delves deep into the intricate mechanisms underlying the metastasis of oral cancer cells, shedding light on the factors that contribute to the spread of this aggressive disease.
Link to the paper: Identification of Metastatic Cells in Human Oral Cancer Tissue
In addition to the academic publication, the research received recognition in the form of a digest from the journal, available here: eLife Digest. The digest provides a concise overview of the research, making it accessible to a broader audience and emphasizing its significance in the field of cancer research.
The second is a pre-print publication presenting a cutting-edge approach. The research utilizes a microfluidic model of metastasis to unravel the intricate interactions between cancer stem cells and the vasculature in oral cancer. This pre-print represents a leap forward in understanding the complexities of oral cancer metastasis, laying the groundwork for future advancements in therapeutic strategies.
Link to the pre-print: Microfluidic Model of Metastasis in Oral Cancer
In addition to contributing to these studies, Leah has built on these approaches and used our new understanding of the metastatic mechanisms of oral cancer to develop a prognostic signature for oral cancer spread. This is now being trialled in a larger retrospective group of patients which, if initial promising results are confirmed, could pave the way for a clinical test to tailor surgical decision making for oral cancer patients.
Oracle Cancer Trust’s commitment to advancing Head and Neck cancer research is exemplified through the recent successes in Leah’s groundbreaking studies and marks a step forward in the RACE to overcome the Head and Neck cancer crisis.
Follow us
Quick Links
Get in touch
Call 020 3875 8991
Email info@oraclecancertrust.org
Oracle Cancer Trust is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS.
Research Large Grants Programme Opportunity
We’re offering up to £300,000 over three years to support innovative, hypothesis-driven research projects.
12 Days of Christmas Winter Appeal 2024
Counting down 12 days of Christmas with fundraising ideas and keeping in touch with Oracle.
Petition to improve HPV Vaccine Uptake
Petition urges increase to HPV vaccine uptake and reduce preventable cancers caused by HPV.
Concert at Lumley Castle Raises Over £3,500
Magical Christmas Concert at Lumley Castle Raises Over £3,500 for Oracle HNCUK
Seeking Specialists for Late Effects Guidelines
Develop national best practice guidelines for managing late effects of head and neck cancer treatment.
Exciting News! – Smiley Charity Film Award
Our Sign Away Cancer film has been nominated for a Smiley Charity Film Award!
Tractor N’ Tinsel Run & Market
Tractor N’ Tinsel Run & Market is now in its fourth year with over 150 tractors decorated.
Help Beat Head and Neck Cancer
Oracle Head & Neck Cancer UK is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS.